Herr Amy E. 4

Accession 0000914190-25-000019

CIK 0000842023other

View on SEC.gov Company Profile

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 5:24 PM ET

Size

26.1 KB

Accession

0000914190-25-000019

Insider Transaction Report

Form 4

Period: 2025-10-30

BIO-TECHNE CorpTECH

Herr Amy E.

Director

Transactions

Award
Stock Option (Right to Buy)
2025-10-30+3,777→ 3,777 total
Exercise: $60.96Exp: 2035-10-30→ Common Stock (3,777 underlying)
Award
Common Stock
2025-10-30+1,640→ 2,680 total

Holdings

Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (6,636 underlying)
6,636
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (1,084 underlying)
1,084
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $53.60Exp: 2035-08-15→ Common Stock (2,735 underlying)
2,735
Common Stock
(indirect: By significant other)
2,154
Stock Option (Right to Buy)
Exercise: $72.05From: 2025-10-24Exp: 2035-02-03→ Common Stock (2,415 underlying)
2,415
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (2,076 underlying)
2,076
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (2,104 underlying)
2,104
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $72.05Exp: 2035-02-03→ Common Stock (344 underlying)
344
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (932 underlying)
932
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (4,472 underlying)
4,472
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (320 underlying)
320
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (1,468 underlying)
1,468
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (118 underlying)
118
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (115 underlying)
115

Footnotes (12)

[F1]This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
[F10]38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
[F11]311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
[F12]Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.
[F2]Fully vested.
[F3]Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
[F4]Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
[F5]Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
[F6]Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
[F7]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F8]118 restricted stock units vest on 8/15/2026.
[F9]160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIO-TECHNE Corp

CIK 0000842023

→

Entity typeother

Related Parties

filerCIK 0002055523

Filing Metadata

Form type: 4
Filed: Nov 2, 7:00 PM ET
Accepted: Nov 3, 5:24 PM ET
Size: 26.1 KB

View on SEC.gov